WO2005121793A3 - Detection of methamphetamine group drugs - Google Patents

Detection of methamphetamine group drugs Download PDF

Info

Publication number
WO2005121793A3
WO2005121793A3 PCT/GB2005/050087 GB2005050087W WO2005121793A3 WO 2005121793 A3 WO2005121793 A3 WO 2005121793A3 GB 2005050087 W GB2005050087 W GB 2005050087W WO 2005121793 A3 WO2005121793 A3 WO 2005121793A3
Authority
WO
WIPO (PCT)
Prior art keywords
methamphetamine
drugs
detection
binding
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2005/050087
Other languages
French (fr)
Other versions
WO2005121793A2 (en
Inventor
Ahmed Mohammed Taki Jehanli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Concateno UK Ltd
Original Assignee
Cozart Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cozart Bioscience Ltd filed Critical Cozart Bioscience Ltd
Priority to CN200580019287.1A priority Critical patent/CN1977166B/en
Priority to HK07104016.5A priority patent/HK1097320B/en
Priority to EP05748983A priority patent/EP1756575B1/en
Priority to AU2005252868A priority patent/AU2005252868B2/en
Priority to US11/629,603 priority patent/US7888040B2/en
Priority to DE602005010579T priority patent/DE602005010579D1/en
Publication of WO2005121793A2 publication Critical patent/WO2005121793A2/en
Publication of WO2005121793A3 publication Critical patent/WO2005121793A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Fire-Detection Mechanisms (AREA)
  • Check Valves (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides immunoassays which are highly specific for detection in biological samples of methamphetamine and other drugs of abuse of the methamphetamine group such as ecstasy and other ecstasy class drugs. More particularly, competitive assays are provided comprising: (a) contacting said sample with (i) a pseudoephedrine/carrier conjugate in which pseudoephedrine is linked via its hydroxyl group to the carrier and (ii) an antibody which is capable of binding both one or more drugs of the methamphetamine group and said conjugate; and (b) determining whether the binding of said antibody to said conjugate is reduced by the presence of said sample, a reduction in binding being indicative that the sample contains a methamphetamine group drug.
PCT/GB2005/050087 2004-06-14 2005-06-10 Detection of methamphetamine group drugs Ceased WO2005121793A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN200580019287.1A CN1977166B (en) 2004-06-14 2005-06-10 Detection of methamphetamine class of drugs
HK07104016.5A HK1097320B (en) 2004-06-14 2005-06-10 Detection of methamphetamine group drugs
EP05748983A EP1756575B1 (en) 2004-06-14 2005-06-10 Detection of methamphetamine group drugs
AU2005252868A AU2005252868B2 (en) 2004-06-14 2005-06-10 Detection of methamphetamine group drugs
US11/629,603 US7888040B2 (en) 2004-06-14 2005-06-10 Detection of methamphetamine group drugs
DE602005010579T DE602005010579D1 (en) 2004-06-14 2005-06-10 DETECTION OF MEDICAMENTS OF THE METHAMPHETAMINE GROUP

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0413225.4 2004-06-14
GB0413225A GB2404022B (en) 2004-06-14 2004-06-14 Competitive assays for the detection of methamphetamine group drugs

Publications (2)

Publication Number Publication Date
WO2005121793A2 WO2005121793A2 (en) 2005-12-22
WO2005121793A3 true WO2005121793A3 (en) 2006-09-14

Family

ID=32732451

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2005/050087 Ceased WO2005121793A2 (en) 2004-06-14 2005-06-10 Detection of methamphetamine group drugs

Country Status (9)

Country Link
US (1) US7888040B2 (en)
EP (1) EP1756575B1 (en)
CN (1) CN1977166B (en)
AT (1) ATE412179T1 (en)
AU (1) AU2005252868B2 (en)
DE (1) DE602005010579D1 (en)
ES (1) ES2314665T3 (en)
GB (1) GB2404022B (en)
WO (1) WO2005121793A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404022B (en) 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
GB2404023B (en) 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method
US10488408B2 (en) 2006-05-09 2019-11-26 Koninklijke Philips N.V. Detection of target molecules in a sample by using a magnetic field
WO2008130680A1 (en) 2007-04-20 2008-10-30 Quidel Corporation Analytical devices with intedrated desiccant
CN101377482B (en) * 2007-08-27 2012-04-25 中国人民解放军总医院 Quality control method of Fengdima eye drops
JP5564491B2 (en) 2008-04-29 2014-07-30 サイケメディクス コーポレイション Solid phase multi-analyte assay
CN101603923B (en) * 2009-06-08 2011-08-17 北京理工大学 Method for surface plasmon resonance detection of medicinal methamphetamine
CN102288760A (en) * 2010-06-18 2011-12-21 北京库尔科技有限公司 Dimethylenedioxyamphetamine detection kit and preparation method thereof
WO2012154306A1 (en) * 2011-05-12 2012-11-15 William Marsh Rice University Bio-nano-chips for on-site drug screening
EP2637021A1 (en) 2012-03-06 2013-09-11 Securetec Detektions-Systeme AG Method and device for detecting analytes
US9423399B2 (en) 2012-09-28 2016-08-23 Takara Bio Usa, Inc. Lateral flow assays for tagged analytes
EP2722669A1 (en) 2012-10-22 2014-04-23 Securetec Detektions-Systeme AG Method and device for detecting illegal drugs
US8986939B1 (en) 2013-08-28 2015-03-24 Psychemedics Corporation Integrity testing of hair samples
ES2964604T3 (en) 2014-07-07 2024-04-08 Attenti Electronic Monitoring Ltd Tamper-proof self-administered drug screening
CN105301236A (en) * 2014-07-25 2016-02-03 江苏维赛科技生物发展有限公司 Preparation and using method of 2-aminobutane colloidal gold test strip
US9817006B2 (en) * 2015-06-19 2017-11-14 Amy J. Reisinger Rapid and sensitive method of forensic toxicology in post-mortem subjects using oral fluid testing
CN107315087A (en) * 2017-06-25 2017-11-03 长沙善道新材料科技有限公司 A kind of MDMA detection kit and preparation method thereof
WO2019018697A1 (en) 2017-07-19 2019-01-24 Evanostics, Llc Cartridges for oral fluid analysis and methods of use
CN109813886A (en) * 2017-11-20 2019-05-28 丹阳亿太生物科技发展有限公司 A kind of Rapid detection test strip detecting chlorpromazine medicament residue
US11262367B2 (en) 2017-12-15 2022-03-01 Evanostics Llc Optical reader for analyte testing
US12066383B2 (en) 2018-12-18 2024-08-20 Aspida Dx Inc. Optical analyte detection
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same
FR3160016A1 (en) 2024-03-08 2025-09-12 Clear Drink Portable test device for the simultaneous detection of multiple psychoactive substances in a beverage sample.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248791A (en) * 1989-04-10 1993-09-28 Abbott Laboratories Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
EP1340981A2 (en) * 2002-03-01 2003-09-03 Roche Diagnostics GmbH Antibodies for detecting amphetamine derivatives
GB2404022A (en) * 2004-06-14 2005-01-19 Cozart Bioscience Ltd Detection of methamphetamine class of drugs
WO2005090987A1 (en) * 2004-03-17 2005-09-29 Cozart Bioscience Limited Procedure for manufacture of strips for lateral flow immunochromatographic devices

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067774A (en) 1971-05-14 1978-01-10 Syva Company Compounds for enzyme amplification assay
US5840588A (en) * 1971-05-20 1998-11-24 Strahilevitz; Meir Agglutination inhibition assay methods and reagents for psychoactive substances
US3996344A (en) 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4041076A (en) 1974-10-23 1977-08-09 Hoffmann-La Roche Inc. Immunoassay for pharmacologically active phenethylamines
US4016146A (en) 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US4329281A (en) 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
US4771005A (en) * 1983-06-27 1988-09-13 Erez Forensic Technology Ltd. Reagents, test kits and methods for the detection of cannabinoids
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
US4868132A (en) 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
DE3856421T2 (en) 1987-04-27 2000-12-14 Unilever Nv Specific binding test procedures
EP0311383B1 (en) * 1987-10-09 1993-10-06 Ube Industries, Ltd. Monoclonal antibody to methamphetamine, preparation of the same, assay method and assay kit of methamphetamine
US4843020A (en) * 1988-01-14 1989-06-27 Woodford W James Method for detecting tetrahydrocannabinol in human urine involving melanin precipitation
US5026827A (en) * 1988-09-02 1991-06-25 Matsushita Electric Industrial Co., Ltd. Amphetamine-protein complex as immunogen for obtaining antibodies specific to methamphetamine
ES2079368T3 (en) 1988-10-28 1996-01-16 Abbott Lab METHOD AND REAGENTS TO DETECT AMPHETAMINES AND / OR D-META-AMPHETAMINES IN BIOLOGICAL SAMPLES.
US5101015A (en) * 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
US5279955A (en) * 1991-03-01 1994-01-18 Pegg Randall K Heterofunctional crosslinking agent for immobilizing reagents on plastic substrates
GB2339615B (en) 1998-07-14 2001-02-07 Cozart Bioscience Ltd Screening device and method of screening an immunoassay test
GB2361473C (en) 2000-03-08 2005-06-28 Microgenics Corp Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
US6534325B1 (en) 2000-06-30 2003-03-18 Roche Diagnostics Corporation Immunoassay for the detection of amphetamines, methamphetamines and methylenedioxy designer amphetamines
SE0002820L (en) 2000-08-04 2002-02-05 Jordanian Pharmaceutical Mfg & Medical kit
US6472228B2 (en) 2000-12-04 2002-10-29 Lifepoint, Inc. Composition and methods for synthesis of novel tracers for detecting amphetamine and methamphetamine in samples
US6492127B2 (en) * 2001-01-23 2002-12-10 Varian, Inc. Lateral flow testing device with on-board chemical reactant
CN1187618C (en) * 2002-11-22 2005-02-02 上海凯创生物技术有限公司 Reagent box for fast detecting methyl amphetamine and its preparation process
US6991911B2 (en) * 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
GB2404023B (en) 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248791A (en) * 1989-04-10 1993-09-28 Abbott Laboratories Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
EP1340981A2 (en) * 2002-03-01 2003-09-03 Roche Diagnostics GmbH Antibodies for detecting amphetamine derivatives
WO2005090987A1 (en) * 2004-03-17 2005-09-29 Cozart Bioscience Limited Procedure for manufacture of strips for lateral flow immunochromatographic devices
GB2404022A (en) * 2004-06-14 2005-01-19 Cozart Bioscience Ltd Detection of methamphetamine class of drugs

Also Published As

Publication number Publication date
WO2005121793A2 (en) 2005-12-22
CN1977166B (en) 2013-01-30
EP1756575B1 (en) 2008-10-22
GB2404022B (en) 2005-08-10
EP1756575A2 (en) 2007-02-28
AU2005252868B2 (en) 2011-02-03
DE602005010579D1 (en) 2008-12-04
US7888040B2 (en) 2011-02-15
GB2404022A (en) 2005-01-19
ATE412179T1 (en) 2008-11-15
GB2404022A9 (en) 2005-01-20
GB2404022A8 (en) 2005-01-20
GB0413225D0 (en) 2004-07-14
CN1977166A (en) 2007-06-06
US20080286816A1 (en) 2008-11-20
HK1097320A1 (en) 2007-06-22
ES2314665T3 (en) 2009-03-16
AU2005252868A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
WO2005121793A3 (en) Detection of methamphetamine group drugs
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
GB9804083D0 (en) Immunoassays
WO2008051762A3 (en) Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
AU2003224447A1 (en) Device and method to simultaneously detect different antibodies and antigens in clinical alimentary and environmental samples
WO2006124641A3 (en) Anti-mesothelin antibodies useful for immunological assays
HRP20140675T1 (en) Elisa for vegf
WO2005084210A3 (en) Multiplex detection probes
WO2011147563A8 (en) Method for electrochemically detecting binding reactions
TW200741203A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
WO2002037102A3 (en) Methods for analyzing dynamic changes in cellular informatics
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE447712T1 (en) IMMUNOASSAY WITH DOUBLE STANDARD CURVE
FI2645106T4 (en) Methods for evaluating an immune response to a therapeutic agent
ATE553386T1 (en) BLOOD TYPING
WO2003106649A3 (en) Assay conjugate and uses thereof
ATE405837T1 (en) SOLID PHASE IMMUNOCHROMATOGRAPHIC TESTING METHODS
WO2003102541A3 (en) Universal biosensor and methods of use
WO2010011775A3 (en) Detection and quantification of antigens
WO2004081025A3 (en) Differential megaplex immunoassay
EP2444812A3 (en) Improved immunoassay methods
WO2007076013A3 (en) Homocysteine immunoassay
WO2007028580A3 (en) Single receptor assays for immunosuppressive drugs
EP2674757A3 (en) Agglutination assay
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005748983

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2005252868

Country of ref document: AU

Ref document number: 200580019287.1

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

ENP Entry into the national phase

Ref document number: 2005252868

Country of ref document: AU

Date of ref document: 20050610

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005252868

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2005748983

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11629603

Country of ref document: US